Total Payments
$156,335
2024 Payments
$13,873
Companies
36
Transactions
317
Medicare Patients
3,257
Medicare Billing
$213,792
Payment Breakdown by Category
Other$105,091 (67.2%)
Consulting$24,580 (15.7%)
Travel$19,611 (12.5%)
Food & Beverage$6,838 (4.4%)
Education$186.26 (0.1%)
Gifts$29.11 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $54,716 | 30 | 35.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $47,125 | 15 | 30.1% |
| Consulting Fee | $24,580 | 15 | 15.7% |
| Travel and Lodging | $19,611 | 86 | 12.5% |
| Food and Beverage | $6,838 | 136 | 4.4% |
| Honoraria | $3,250 | 2 | 2.1% |
| Education | $186.26 | 6 | 0.1% |
| Gift | $29.11 | 21 | 0.0% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
General
$156,335
311 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valeant Pharmaceuticals North America LLC | $59,588 | 74 | $0 (2017) |
| AMAG Pharmaceuticals, Inc. | $51,258 | 98 | $0 (2018) |
| ASCEND THERAPEUTICS US, LLC | $17,924 | 29 | $0 (2024) |
| DySIS Medical, Inc. | $9,654 | 15 | $0 (2022) |
| Astellas Pharma US Inc | $8,706 | 12 | $0 (2024) |
| Sprout Pharmaceuticals, Inc. | $4,180 | 1 | $0 (2018) |
| TherapeuticsMD, Inc. | $2,448 | 9 | $0 (2020) |
| ABBVIE INC. | $427.49 | 15 | $0 (2024) |
| SCYNEXIS, Inc. | $383.39 | 3 | $0 (2022) |
| Myovant Sciences Inc. | $289.62 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,873 | 18 | ASCEND THERAPEUTICS US, LLC ($13,001) |
| 2023 | $11,855 | 24 | Astellas Pharma US Inc ($8,023) |
| 2022 | $10,900 | 34 | DySIS Medical, Inc. ($8,932) |
| 2021 | $1,251 | 23 | DySIS Medical, Inc. ($700.00) |
| 2020 | $371.02 | 16 | MERZ NORTH AMERICA, INC. ($124.37) |
| 2019 | $2,649 | 14 | TherapeuticsMD, Inc. ($2,421) |
| 2018 | $47,291 | 90 | AMAG Pharmaceuticals, Inc. ($42,931) |
| 2017 | $68,144 | 98 | Valeant Pharmaceuticals North America LLC ($59,588) |
All Payment Transactions
317 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $515.00 | General |
| 09/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Biological | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: HORMONE THERAPY | ||||||
| 07/23/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: CONTRACEPTIVE | ||||||
| 05/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Biological | ||||||
| 04/26/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Women's Health | ||||||
| 04/22/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 04/09/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Women's Health | ||||||
| 03/19/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.50 | General |
| Category: Women's Health | ||||||
| 03/19/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.20 | General |
| Category: Women's Health | ||||||
| 02/21/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Women's Health | ||||||
| 02/21/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Women's Health | ||||||
| 02/06/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: CONTRACEPTIVE | ||||||
| 02/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $106.15 | General |
| Category: Obesity | ||||||
| 01/09/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.20 | General |
| Category: Women's Health | ||||||
| 01/08/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 2024 | Unified Women's Healthcare, LP | — | — | — | $0.00 | Ownership |
| 12/06/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,575.00 | General |
| Category: Biological | ||||||
| 12/06/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $122.94 | General |
| Category: Biological | ||||||
| 11/28/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.20 | General |
| Category: Women's Health | ||||||
| 11/16/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Honoraria | Cash or cash equivalent | $750.00 | General |
| Category: Women's Health | ||||||
| 11/01/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Biological | ||||||
| 10/17/2023 | AbbVie Inc. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: WOMENS HEALTH | ||||||
| 10/17/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.20 | General |
| Category: Women's Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 859 | 916 | $247,197 | $60,879 |
| 2022 | 18 | 750 | 826 | $214,831 | $51,632 |
| 2021 | 11 | 784 | 847 | $130,955 | $51,265 |
| 2020 | 16 | 864 | 1,049 | $165,055 | $50,017 |
Total Patients
3,257
Total Services
3,638
Medicare Billing
$213,792
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 76641 | Complete ultrasound scan of 1 breast | Office | 2022 | 21 | 25 | $8,175 | $2,007 | 24.6% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 92 | 92 | $4,600 | $1,644 | 35.7% |
| 57160 | Fitting and insertion of vaginal support device | Office | 2022 | 12 | 20 | $4,500 | $1,272 | 28.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 25 | 25 | $3,300 | $1,113 | 33.7% |
| 58100 | Biopsy of lining of uterus | Office | 2022 | 12 | 12 | $3,792 | $1,020 | 26.9% |
| A4562 | Pessary, non rubber, any type | Office | 2022 | 11 | 16 | $1,760 | $793.60 | 45.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 42 | 42 | $2,394 | $782.61 | 32.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 15 | 15 | $3,600 | $575.33 | 16.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 12 | 12 | $972.00 | $330.56 | 34.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 29 | 39 | $390.00 | $127.47 | 32.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 169 | 182 | $41,860 | $16,855 | 40.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 185 | 232 | $34,800 | $15,004 | 43.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 56 | 56 | $20,160 | $6,696 | 33.2% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 204 | 204 | $10,200 | $3,682 | 36.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 44 | 44 | $10,120 | $3,657 | 36.1% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 20 | 21 | $6,090 | $2,072 | 34.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 28 | 28 | $3,080 | $1,275 | 41.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 25 | 25 | $3,125 | $1,047 | 33.5% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 14 | 14 | $560.00 | $560.00 | 100.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2021 | 11 | 11 | $660.00 | $311.08 | 47.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 28 | 30 | $300.00 | $104.40 | 34.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 206 | 266 | $39,900 | $13,575 | 34.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 154 | 162 | $37,260 | $11,963 | 32.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 62 | 62 | $14,260 | $4,546 | 31.9% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2020 | 207 | 207 | $10,350 | $3,723 | 36.0% |
About Dr. Maureen Whelihan, M.D
Dr. Maureen Whelihan, M.D is a Gynecology healthcare provider based in Greenacres, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104913102.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maureen Whelihan, M.D has received a total of $156,335 in payments from pharmaceutical and medical device companies, with $13,873 received in 2024. These payments were reported across 317 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($54,716).
As a Medicare-enrolled provider, Whelihan has provided services to 3,257 Medicare beneficiaries, totaling 3,638 services with total Medicare billing of $213,792. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Greenacres, FL
- Active Since 10/10/2006
- Last Updated 12/15/2025
- Taxonomy Code 207VG0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104913102
Products in Payments
- ADDYI (Drug) $59,588
- INTRAROSA (Drug) $47,750
- ESTROGEL (Drug) $17,917
- DYSIS ULTRA (Device) $8,932
- Veozah (Drug) $8,041
- addyi (Drug) $4,180
- BREMELANOTIDE (Drug) $3,493
- IMVEXXY (Drug) $2,305
- DYSIS Ultra (Device) $700.00
- MYFEMBREE (Drug) $328.78
- EVENITY (Biological) $232.88
- LO LOESTRIN FE (Drug) $202.33
- Orilissa (Drug) $161.24
- Wegovy (Drug) $129.01
- XEOMIN (Biological) $124.37
- BIJUVA (Drug) $115.95
- Myosure and NovaSure (Device) $109.52
- Phexxi (Drug) $93.09
- Lupron (Drug) $90.26
- SLYND (Drug) $85.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.